Sutro Biopharma Inc (STRO) Unusual Options Activity Today

Checking STRO unusual options activity helps you spot when traders are making outsized bets on Sutro Biopharma Inc before the broader market catches on. Sutro Biopharma Inc's unusual options activity flags contracts trading at multiples of their average daily volume, often signaling that informed money is positioning ahead of a catalyst. Use our scanner to monitor STRO unusual options activity today and surface the prints that deserve a second look.

Unusual options flow typically refers to trades where volume vastly exceeds open interest at a given strike, or where total contract volume on a name spikes well above its norm. Watching STRO unusual options flow today can reveal large block trades, sweeps across exchanges, and aggressive directional bets. Tracking STRO unusual options volume across calls and puts helps you separate hedging activity from genuinely speculative positioning, and STRO unusual options flow data becomes especially valuable around earnings, product launches, and macro events.

Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-drug conjugate (ADC) directed against the cancer target CD74 for patients with multiple myeloma and non-Hodgkin lymphoma that is in Phase 1 clinical trials; and STRO-002, an ADC directed against folate receptor-alpha for patients with ovarian and endometrial cancers, which is in Phase 1 clinical trials.

It has collaboration and license agreements with Merck Collaboration to develop research programs focusing on cytokine derivatives for cancer and autoimmune disorders; and Celgene Corporation to discover and develop bispecific antibodies and/or ADCs focused on the field of immuno-oncology. The company was formerly known as Fundamental Applied Biology, Inc. Sutro Biopharma, Inc. was incorporated in 2003 and is headquartered in South San Francisco, California.

Catalysts rarely arrive without a footprint, and STRO unusual options activity is often where that footprint shows up first. Our scanner tracks Sutro Biopharma Inc's unusual options flow in real time, ranks prints by volume-to-open-interest, premium spent, and aggressor side, and separates real conviction from noise. Whether you're looking at STRO unusual options volume on the call side or chasing put sweeps, Sutro Biopharma Inc's unusual options flow today is one click away, so put it on your radar before the headlines hit.